Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061113 · ClinicalTrials.gov registry record · Phase 4
Substance Dependent Teens - Impact of Treating Depression Study 1 - 1
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT00061113: Completed Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00061113 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 126 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00061113, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of treating depression on substance dependent teens.
Interventions
- DRUG fluoxetine
- DRUG Fluoxetine + outpatient cognitive behavioral therapy
- DRUG placebo + CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2001-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
What the finished NCT00061113 record still lists
NCT00061113 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 3 interventions - of which fluoxetine is the first listed.
NCT00061113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00061113 about?
NCT00061113 is a clinical study titled "Substance Dependent Teens - Impact of Treating Depression Study 1 - 1". The purpose of this study is to evaluate the impact of treating depression on substance dependent teens.
What is the current status of trial NCT00061113?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2001-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00061113?
The interventions under investigation include: fluoxetine (DRUG), Fluoxetine + outpatient cognitive behavioral therapy (DRUG), placebo + CBT (DRUG).
Who is sponsoring clinical trial NCT00061113?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00061113's enrollment target sits among peer trials
126 646th of 2000 higher than 1,354 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia